Januar 2010
The LEVA® autoinjector from Bang & Olufsen Medicom wins ’2009 GOOD DESIGN™ Award’
B&O Medicom, Struer, Denmark, January 14 2010:
Designed and developed in Denmark and aimed at patients globally. The innovative and user friendly LEVA® autoinjector has received the prestigious design award ’GOOD DESIGN’.
The Chicago Athenaeum founded the GOOD DESIGN program in 1950 and today it is one of the most recognized programs for design excellence worldwide. Early participants were formable designers including Eero Saarinen, and Charles and Ray Eames.
Every year the program sees a large number of entries from around the world. This year submitted designs ranged from manned Mars exploration vehicles to clean water filtering systems. 500 designs from 35 countries received the attractive GOOD DESIGN Award for design distinction. The LEVA® auto injector was one of them.
’We are proud of this recognition of our constant strive for making drug delivery devices that are intuitive, user friendly and less stigmatizing for the patient. Patient research shows this as key to getting the optimal outcome of medical treatment’, says Peter W. Ravn who is in charge of sales and marketing with B&O Medicom. ’A well designed device, developed around patient needs has a lot of importance when it comes to injectable drugs. Patient acceptance of treatment is closely related to understanding his/her role. An easy-to-use device thus allows for home treatment which in addition lowers cost to society. This is our speciality - understanding and involving the patient and other key stakeholders when we innovate’ continues Peter W. Ravn.
LEVA® is developed with and for the patient suffering from chronic diseases like rheumatoid arthritis and multiple sclerosis. Modern, biologic drugs for home usage are often part of the treatment for these patients. B&O Medicom is working with a number of leading pharmaceutical companies to bring LEVA® to the patient.
B&O Medicom is a global, Danish company, specialized in the development and manufacturing of user-friendly drug delivery device solutions and services. Inhalation, injection and tablet dispensing are and have been key focus areas for more than 20 years. Medicom employs around 80 employees in locations in Struer and in Copenhagen and more than 80% of the business is exported.
LEVA® is a disposable autoinjector, designed to automatically deliver a single dosage when activated by the patient. It is developed by B&O Medicom and is to be used for injectable drugs.
For more information about B&O Medicom: medicomnordic.com or about Chicago Athenaeum: chi-athenaeum.org
November 2009
Lyde du kan stole på - pressemeddelse fra 3M Danmark
3M lancerer den nyeste udvikling af det velkendte Littmann® elektroniske stetoskop, der nu gennemsnitligt reducerer 85% af udefrakommende støj. Model 3100 er markant lettere at bruge end de tidligere modeller – og så er det designet og udviklet af B&O Medicom.
Click here to read more
B&O Medicom enters collaboration to develop new, leading inhaler platform
B&O Medicom, Struer, Denmark, March 25 2009: B&O Medicom has entered a 3 year collaboration with a major pharmaceutical company to develop a next generation inhaler platform. The new platform will be leading edge when it comes to user friendliness and it will enable a safe and easy inhalation of drugs targeting asthma and COPD.
Medicom’s extensive and year long experience with the development and manufacturing of user-friendly inhalators has made it a global leader in this field. More than 40 skilled engineers and a range of patented technologies has made many, major pharmaceutical companies turn to the Struer based company. 4 of the 10 largest pharma companies are currently engaged in projects with Medicom.
The new inhalation platform represents a milestone for B&O Medicom. The outcome will be a technological solution that, especially for the elderly and for children, will be perceived as a major improvement versus current inhalers. The improvements will be reached through easier coordination between the breathing and the handling of the device. The simplicity, the user friendliness and a feedback mechanism gives confidence to the user that the medication has been performed correctly explains Henrik Kagenow, CEO of B&O Medicom.
B&O Medicom is a global, Danish company, specialised in the development and manufacturing of user-friendly drug delivery device solutions and services. Inhalation, injection and tablet dispensing are and have been key focus areas for more than 20 years. Medicom employs around 100 employees in locations in Struer and in Copenhagen and more than 80% of the business is exported.
Contact: Henrik Kagenow, CEO, tel. +45 21 61 62 97, or
Peter W. Ravn, Vice President, Sales & Marketing, tel. +45 61 20 05 04